Diabetes

Top Story

Novel antihyperglycemic agents, multidisciplinary care model impact cardiorenal outcomes

Novel antihyperglycemic agents, multidisciplinary care model impact cardiorenal outcomes
April 6, 2020
In the Journals

Urinary biomarker pattern may predict progression of CKD in type 2 diabetes

April 2, 2020
“We have proven, for the first time in a prospective study, that the urinary proteomic-based analysis CKD273 works as a predictor for future risk for progression…
Meeting News

Artificial intelligence-enabled test may substantially reduce costs related to diabetic kidney disease

March 31, 2020
For patients with diabetic kidney disease, using an artificial intelligence-enabled diagnostic test to predict rapid kidney function decline and kidney failure could…

DAPA-CKD trial stopped early after ‘overwhelming benefit’ observed with dapagliflozin

March 30, 2020
The phase 3 DAPA-CKD trial assessing the benefit of the SGLT2 inhibitor dapagliflozin in adults with chronic kidney disease will be stopped early after investigators…
More Headlines »
CME

One Size Does Not Fit All: Opportunities for Improving Heart Failure Outcomes in Special Populations

Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Novartis Pharmaceuticals Corporation.

More »
CME Article

Facing Diabetes: A Guide for Psychiatric Providers

Psychiatric Annals, February 2019, Volume 49 Issue 2
Chronic medical conditions, such as diabetes mellitus, are often closely intertwined with psychiatric disorders…
More »